Hint mode is switched on Switch off

Innate Pharma, ordinary share
FR0010331421, IPH

Add a stock to WL
Innate Pharma, сountry — France
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
from
to
ADD-IN
Cbonds add-in
API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Latest quotes

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way
Bond Search
Watchlist
Excel ADD-IN
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Issuer

  • Issuer
  • Full borrower / issuer name
    Innate Pharma S.A.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    IPHA
  • Placement
    17.10.2019
  • Lock up period
    180
  • Number of papers
    12,500,000
  • Volume of raised funds
    68.75 mln USD
  • Placement share
    16.33%
  • Final placement price
    5.5 USD
  • Price change since placement date
    -57.27%
  • By capitalization
    420.99 mln USD

IFRS/US GAAP reports

2023
2022
2021
2020
2019
Authorization required
You need to request access

Related Stock indices

Indicators

Other stocks and deposit receipts

Holders

Industry Leaders

Registration is required to get access.